Business Wire

GSMA Announces Vice-President Ansip, Commissioner Oettinger and Belgian Deputy Prime Minister De Croo Will Speak at Mobile 360 Series – Europe


The GSMA announced today that European Commission Vice-President for the Digital Single Market, Andrus Ansip, and Günther Oettinger, EU Commissioner for Digital Economy and Society, as well as Alexander De Croo, Belgian Deputy Prime Minister and Minister of Development Cooperation, Digital Agenda, Telecom and Postal Services, will speak at the Mobile 360 Series – Europe conference taking place on Tuesday, 14 June at The Egg, Brussels. The event will bring together EU policy and industry leaders to explore trends and innovation across the rapidly evolving mobile ecosystem. It will also examine how the mobile ecosystem can contribute to driving growth, competitiveness and job creation across all European sectors.

Confirmed speakers for the event include:

  • Vincent Rousselet, VP, Market Insight and Strategy, Amdocs
  • David Maidment, Lead Mobile Strategist, ARM
  • Mark Page, Managing Partner, UK and Ireland, A.T. Kearney
  • Tom Platt, Commercial Director, BCSG
  • Philippe Defraigne, Founding Director, Cullen International
  • Andrus Ansip, Vice-President for the Digital Single Market, European Commission
  • Günther H. Oettinger, Commissioner for Digital Economy and Society, European Commission
  • Tal Brockmann, CEO, Finnovest
  • Aideen O'Colmain, Corporate Wellness Director, FitBit
  • Jon Fredrik Baksaas, Chairman, GSMA
  • Mats Granryd, Director General, GSMA
  • Peter Globokar, MD, Mooreland Partners
  • Pierre Louette, Deputy CEO, Orange
  • Sébastien Deletaille, Co-Founder and CEO, Real Impact Analytics
  • Janice Hughes, Co-Founder & Director, Redshift
  • Guy Stiebel, VP, Product Development and Marketing, Scanovate
  • Roi Carthy, CMO, Shine Technologies
  • Lars Torstensson, EVP Group Communication and Strategy, Tele2
  • Alexander De Croo, Deputy Prime Minister of Belgium and Minister of Development Cooperation, Digital Agenda, Telecom and Postal Services
  • Aditya Kaul, Research Director, Tractica
  • Kaan Terzioğlu, CEO, Turkcell

The event will highlight the impact that 5G technologies will have in the coming years, with a particular focus on enterprise services, financial technology, media and wearable devices. It will also examine the opportunities these mobile and digital technologies can provide in a European Digital Single Market. Furthermore, it will discuss how different industries and policy makers can work in partnership to ensure digital policies can enable mobile's potential in the European Union.

“Today, Europe has a chance to pave the way for digital innovation and leadership in the global mobile ecosystem. We believe that exchanging ideas and debating the current barriers, as well as solutions, at events like Mobile 360 – Europe can significantly contribute to driving economic growth and social progress across the region,” said Afke Schaart, Vice President Europe, GSMA. “We look forward to continuing the dialogue and debate amongst all key stakeholders in the mobile ecosystem.”

Mobile 360 – Europe Registration Now Open

Registration for Mobile 360 – Europe is now open. Individuals wishing to attend should visit Press and industry analysts wishing to apply for accreditation to Mobile 360 – Europe should contact The press team will provide the criteria for accreditation and further information on the application process.

Get Involved at Mobile 360 – Europe

The 2016 GSMA Mobile 360 – Europe conference is part of a series of seven regional and industry-focused events held in major cities across the world. For full information on Mobile 360 – Europe, including the agenda and speakers, please visit Follow developments and updates on Mobile 360 – Europe (#m360Europe) and the Mobile 360 series (#mobile360) on Twitter @GSMA and on Facebook

Mobile 360 – Europe 2016 sponsors and partners

Global Industry Supporter: Huawei

Exclusive Sponsor: Ericsson

Official Media Partner: Mobile World Live

Global Partner: Mobile World Capital Barcelona

Supporting Partners: Cullen International, EurActiv, The European Sting, GlobalPlatform, The Mobile Network, SIMalliance, Smart Insights, Telco Professionals, Telecompaper


About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 250 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai and the Mobile 360 Series conferences.

For more information, please visit the GSMA corporate website at Follow the GSMA on Twitter: @GSMA.

Contact information

Media Contacts
For the GSMA:
Ruta Malinauskaite
+32 (0) 492 46 73 04
GSMA 360 Press Office:

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on